Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Dec 24;12(1):15.
doi: 10.3390/genes12010015.

Non-Invasive Prenatal Testing: Current Perspectives and Future Challenges

Luigi Carbone  1 , Federica Cariati  2   3 , Laura Sarno  1 , Alessandro Conforti  1 , Francesca Bagnulo  3 , Ida Strina  1   3 , Lucio Pastore  2   4 , Giuseppe Maria Maruotti  1 , Carlo Alviggi  1   3   5
Affiliations
Review

Non-Invasive Prenatal Testing: Current Perspectives and Future Challenges

Luigi Carbone et al. Genes (Basel). .

Abstract

Fetal aneuploidies are among the most common causes of miscarriages, perinatal mortality and neurodevelopmental impairment. During the last 70 years, many efforts have been made in order to improve prenatal diagnosis and prenatal screening of these conditions. Recently, the use of cell-free fetal DNA (cff-DNA) testing has been increasingly used in different countries, representing an opportunity for non-invasive prenatal screening of pregnant women. The aim of this narrative review is to describe the state of the art and the main strengths and limitations of this test for prenatal screening of fetal aneuploidies.

Keywords: cell-free fetal DNA; fetal aneuploidies; fetal fraction; non-invasive prenatal testing; prenatal screening.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Non-invasive prenatal test (NIPT) analysis. CNVs: copy number variations, SNPs: single nucleotide polymorphisms.
See this image and copyright information in PMC

References

    1. Steele M.W., Breg W.R., Jr. Chromosome analysis of human amniotic-fluid cells. Lancet. 1966;1:383–385. doi: 10.1016/S0140-6736(66)91387-0. - DOI - PubMed
    1. Nadler H.L., Gerbie A.B. Role of amniocentesis in the intrauterine detection of genetic disorders. N. Engl. J. Med. 1970;282:596–599. doi: 10.1056/NEJM197003122821105. - DOI - PubMed
    1. Holzgreve W., Hogge W.A., Golbus M.S. Chorion villi sampling (CVS) for prenatal diagnosis of genetic disorders: First results and future research. Eur. J. Obstet. Gynecol. Reprod. Biol. 1984;17:121–130. doi: 10.1016/0028-2243(84)90135-7. - DOI - PubMed
    1. Simoni G., Brambati B., Danesino C., Rossella F., Terzoli G.L., Ferrari M., Fraccaro M. Efficient direct chromosome analyses and enzyme determinations from chorionic villi samples in the first trimester of pregnancy. Hum. Genet. 1983;63:349–357. doi: 10.1007/BF00274761. - DOI - PubMed
    1. Beta J., Lesmes-Heredia C., Bedetti C., Akolekar R. Risk of miscarriage following amniocentesis and chorionic villus sampling: A systematic review of the literature. Minerva Ginecol. 2018;70:215–219. doi: 10.23736/S0026-4784.17.04178-8. - DOI - PubMed

MeSH terms

Substances